What's breaking now, across thousands of outlets.
Key PointsVanEck Biotech ETF offers a more affordable expense ratio of 0.35% compared to 0.57% for Invesco Pharmaceuticals ETF.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
Nigeria has recorded a new milestone in advanced cancer treatment with the deployment of Actinium-based radiopharmaceutical therapy at Loveworld Medical read more Nigeria records new cancer treatment…
Cases of a parasitic illness linked to iceberg lettuce have been confirmed in 20 states, health officials said, as the largest outbreak of the disease in U.S. history keeps growing.
A recent study led by the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), in collaboration with the Correctional Services…
FDA cancels Cipla unit's drug licence: During an inspection in June, FDA officials found that the packaging of Reactin Plus Tablets, a Schedule H prescription medicine, carried an unauthorised claim…
Moderna’s upsized note offering quickly followed a big win in a crucial study. Elsewhere, a biotech’s shares tumbled after study data were “inadvertently” published ahead of a medical meeting.
New research by Malaghan's Connor Laboratory, published in PNAS, shows how directing the immune system toward conserved areas of the COVID virus and its many variants using RNA technology could be a…
